FDA Brass, BigLaw Attys Dish On New Promo Policies
U.S. Food and Drug Administration leaders and BigLaw attorneys gathered at a major industry conference this week to share insights and predictions on evolving agency policies toward drug and device promotion....To view the full article, register now.
Already a subscriber? Click here to view full article